LYSODREN

Lysodren Adverse Events Reported to the FDA Over Time

How are Lysodren adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lysodren, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lysodren is flagged as the suspect drug causing the adverse event.

Most Common Lysodren Adverse Events Reported to the FDA

What are the most common Lysodren adverse events reported to the FDA?

Drug Level Above Therapeutic	22 (2.99%)
Gamma-glutamyltransferase Increased	18 (2.45%)
Cytolytic Hepatitis	17 (2.31%)
Weight Decreased	16 (2.18%)
Vomiting	15 (2.04%)
Asthenia	14 (1.9%)
Dizziness	13 (1.77%)
Fatigue	13 (1.77%)
Malignant Neoplasm Progression	13 (1.77%)
Rash	13 (1.77%)
Somnolence	13 (1.77%)
	Show More
Adrenal Insufficiency	12 (1.63%)
Alanine Aminotransferase Increased	12 (1.63%)
Condition Aggravated	12 (1.63%)
Nausea	12 (1.63%)
Aspartate Aminotransferase Increase...	11 (1.5%)
Anaemia	10 (1.36%)
Death	10 (1.36%)
Diarrhoea	10 (1.36%)
Hepatitis Acute	10 (1.36%)
Overdose	9 (1.22%)
Hepatic Enzyme Increased	8 (1.09%)
Hepatitis	8 (1.09%)
Anorexia	7 (.95%)
Blood Alkaline Phosphatase Increase...	7 (.95%)
Hypokalaemia	7 (.95%)
Tremor	7 (.95%)
Accidental Exposure	6 (.82%)
Blood Lactate Dehydrogenase Increas...	6 (.82%)
Cholestasis	6 (.82%)
Disturbance In Attention	6 (.82%)
Hypercholesterolaemia	6 (.82%)
Hypothyroidism	6 (.82%)
Memory Impairment	6 (.82%)
Neoplasm Progression	6 (.82%)
Psychomotor Hyperactivity	6 (.82%)
Sleep Disorder	6 (.82%)
White Blood Cell Count Decreased	6 (.82%)
Altered State Of Consciousness	5 (.68%)
Aplasia Pure Red Cell	5 (.68%)
Drug Level Below Therapeutic	5 (.68%)
Drug Level Increased	5 (.68%)
Gastrointestinal Disorder	5 (.68%)
Leukopenia	5 (.68%)
Neutropenia	5 (.68%)
Neutrophil Count Decreased	5 (.68%)
Red Blood Cell Count Decreased	5 (.68%)
Speech Disorder	5 (.68%)
Adverse Event	4 (.54%)
Dysphagia	4 (.54%)
Gait Disturbance	4 (.54%)
Liver Disorder	4 (.54%)
Myalgia	4 (.54%)
Renal Failure	4 (.54%)
Abdominal Pain	3 (.41%)
Adrenocortical Carcinoma	3 (.41%)
Aggression	3 (.41%)
Cardiac Arrest	3 (.41%)
Coma	3 (.41%)
Confusional State	3 (.41%)
Decreased Appetite	3 (.41%)
Dehydration	3 (.41%)
Depressed Level Of Consciousness	3 (.41%)
Depression	3 (.41%)
Diplopia	3 (.41%)
Disease Progression	3 (.41%)
Dyspepsia	3 (.41%)
Eosinophil Count Increased	3 (.41%)
Febrile Neutropenia	3 (.41%)
Hyponatraemia	3 (.41%)
Lethargy	3 (.41%)
Liver Function Test Abnormal	3 (.41%)
Neurological Symptom	3 (.41%)
Off Label Use	3 (.41%)
Pelvic Pain	3 (.41%)
Proteinuria	3 (.41%)
Pyrexia	3 (.41%)
Renal Failure Acute	3 (.41%)
Renal Impairment	3 (.41%)
Respiratory Distress	3 (.41%)
Sepsis	3 (.41%)
Septic Shock	3 (.41%)
Thrombocytopenia	3 (.41%)
Transaminases Increased	3 (.41%)
Vertigo	3 (.41%)
Vision Blurred	3 (.41%)
Amnesia	2 (.27%)
Ataxia	2 (.27%)
Blood Count Abnormal	2 (.27%)
Blood Potassium Decreased	2 (.27%)
Cerebral Thrombosis	2 (.27%)
Chills	2 (.27%)
Disorientation	2 (.27%)
Drug Administration Error	2 (.27%)
Dysarthria	2 (.27%)
Epistaxis	2 (.27%)
Feeling Drunk	2 (.27%)
Gastrointestinal Haemorrhage	2 (.27%)
Hepatic Failure	2 (.27%)
Hepatitis Toxic	2 (.27%)
Hypertension	2 (.27%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Lysodren, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lysodren is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lysodren

What are the most common Lysodren adverse events reported to the FDA?

Neurological	58 (7.89%)
Hepatobiliary	57 (7.76%)
Hepatic And Hepatobiliary	52 (7.07%)
Gastrointestinal Signs	38 (5.17%)
Toxicology And Therapeutic Drug Mon...	33 (4.49%)
Hematology Investigations	27 (3.67%)
Epidermal And Dermal Conditions	23 (3.13%)
Miscellaneous And Site Unspecified ...	20 (2.72%)
Medication Errors	19 (2.59%)
Anemias Nonhemolytic And Marrow Dep...	18 (2.45%)
Physical Examination Topics	17 (2.31%)
	Show More
Mental Impairment	15 (2.04%)
Movement Disorders	15 (2.04%)
Enzyme	14 (1.9%)
Electrolyte And Fluid Balance Condi...	13 (1.77%)
White Blood Cell	13 (1.77%)
Adrenal Gland	12 (1.63%)
Fatal Outcomes	12 (1.63%)
Appetite And General Nutritional	11 (1.5%)
Gastrointestinal Motility And Defec...	11 (1.5%)
Infections - Pathogen Unspecified	11 (1.5%)
Renal Disorders	10 (1.36%)
Lipid Metabolism	9 (1.22%)
Vision	9 (1.22%)
Muscle	8 (1.09%)
Cardiac Arrhythmias	7 (.95%)
Respiratory	7 (.95%)
Sleep Disorders	7 (.95%)
Therapeutic And Nontherapeutic Effe...	7 (.95%)
Gastrointestinal Conditions	6 (.82%)
Thyroid Gland	6 (.82%)
Body Temperature Conditions	5 (.68%)
Deliria	5 (.68%)
Embolism And Thrombosis	5 (.68%)
Platelet	5 (.68%)
Endocrine Investigations	4 (.54%)
Personality Disorders	4 (.54%)
Decreased And Nonspecific Blood Pre...	3 (.41%)
Depressed Mood Disorders	3 (.41%)
Encephalopathies	3 (.41%)
Endocrine Neoplasms Malignant And U...	3 (.41%)
Inner Ear And Viiith Cranial Nerve	3 (.41%)
Lipid Analyses	3 (.41%)
Reproductive Tract	3 (.41%)
Therapeutic Procedures And Supporti...	3 (.41%)
Urinary Tract Signs	3 (.41%)
Water, Electrolyte And Mineral	3 (.41%)
Central Nervous System Vascular	2 (.27%)
Endocrine Disorders Of Gonadal Func...	2 (.27%)
Exocrine Pancreas Conditions	2 (.27%)
Gastrointestinal Hemorrhages	2 (.27%)
Neoplasm Related Morbidities	2 (.27%)
Pigmentation	2 (.27%)
Pregnancy, Labour, Delivery And Pos...	2 (.27%)
Pulmonary Vascular	2 (.27%)
Skin Appendage Conditions	2 (.27%)
Upper Respiratory Tract Disorders	2 (.27%)
Vascular Hypertensive	2 (.27%)
Vitamin Related	2 (.27%)
Breast	1 (.14%)
Cardiac And Vascular Investigations	1 (.14%)
Chemical Injury And Poisoning	1 (.14%)
Coagulopathies And Bleeding Diathes...	1 (.14%)
Communication Disorders	1 (.14%)
Cranial Nerve Disorders	1 (.14%)
Eating Disorders	1 (.14%)
Fungal Infectious	1 (.14%)
Gastrointestinal Inflammatory Condi...	1 (.14%)
Injuries	1 (.14%)
Iron And Trace Metal Metabolism	1 (.14%)
Joint	1 (.14%)
Lifestyle Issues	1 (.14%)
Menstrual Cycle And Uterine Bleedin...	1 (.14%)
Metabolic, Nutritional And Blood Ga...	1 (.14%)
Metastases	1 (.14%)
Mood Disorders	1 (.14%)
Ocular Neuromuscular	1 (.14%)
Ovarian And Fallopian Tube	1 (.14%)
Peripheral Neuropathies	1 (.14%)
Pleural	1 (.14%)
Product Quality Issues	1 (.14%)
Psychiatric	1 (.14%)
Renal And Urinary Tract Investigati...	1 (.14%)
Respiratory Tract Therapeutic Proce...	1 (.14%)
Sexual Dysfunctions, Disturbances A...	1 (.14%)
Skin Vascular Abnormalities	1 (.14%)
Vascular Hemorrhagic	1 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lysodren, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lysodren is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.